Atomoxetin

To chci

Atomoxetine is a selective norepinephrine-reuptake inhibitor indicated for the management of ADHD (F90.0) in children over six years of age, adolescents and adults. There is positive evidence for effectiveness of atomoxetine on core ADHD symptomatology and various comorbid conditions and quality of life. Commonly reported side effects, especially in the beginning of treatment, include headache, stomachache and decreased appetite. Atomoxetine can affect heart rate and blood pressure; cardiovascular status should be regularly monitored. The persistence of the therapeutic effect of atomoxetine through 24 hours enables once-daily dosing and thus can maintain efficacy in treating the symptoms of ADHD beyond the initial hours of the day spent in school, such as during afternoon study time, leisure activities or preparing for bed. … celý popis

Podrobná bibliografie

Hlavní autor

Daniela Zmeškalová

Typ dokumentu

Články

Publikováno v

Psychiatrie pro praxi. -- ISSN 1213-0508. -- Ročník 21, číslo 1 (2020), s. 47-[52]

Témata

psychofarmakologie

porucha pozornosti spojená s hyperaktivitou

neuroleptika

stati

Bibliografie

Obsahuje bibliografické odkazy